Schwartz Elissa J. 4
4 · GALECTIN THERAPEUTICS INC · Filed Jan 30, 2023
Insider Transaction Report
Form 4
Schwartz Elissa J.
Director
Transactions
- Award
Stock Option (right to buy)
2023-01-26+40,000→ 40,000 totalExercise: $1.11Exp: 2033-01-26→ Common Stock (40,000 underlying)
Footnotes (2)
- [F1]The stock options were issued pursuant to the Galectin Therapeutics, Inc. 2019 Omnibus Equity Incentive Plan.
- [F2]The options vest 100% on December 31, 2023.